Modular Medical shareholders approve 150% increase in authorized shares and reverse stock split authorization

Modular Medical, Inc.

Authorized common shares increased from 100M to 250M (Proposal 3: 46.75M for, 5.04M against).
Board authorized to effect a reverse stock split at a ratio within a specified range within one year (Proposal 2: 50.6M for).
Equity incentive plan increased by 3M shares (Proposal 4: 35.38M for).
All eight director nominees elected, including CEO James Besser (not a candidate) and Duane DeSisto, Paul DiPerna, Steven Felsher, etc.
Farber Hass Hurley LLP ratified as independent auditor for fiscal year ending March 31, 2026.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Modular Medical, Inc.: Increased authorized shares of common stock from 100,000,000 to 250,000,000 (effective 2026-01-23).

Change: charter amendment
Effective: 2026-01-23

Exact text from the filing

On January 23, 2026, Modular Medical, Inc. (the "Company") filed a certificate of amendment to its Amended and Restated Articles of Incorporation (as amended, the "Amended and Restated Certificate of Incorporation") (the "Charter Amendment"), with the secretary of state of the state of Nevada to increase the Company’s authorized shares of common stock from 100,000,000 to 250,000,000.

View on SEC.gov

80 governance changes filed in the last 30 days. Browse all governance changes →

Modular Medical, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-26-007296

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.